This inventor holds 1 USPTO granted patent. Top assignee: Teijin Pharma Limited. Active years: 2008.
Company Filing History:
Years Active: 2008
Title: Yohei Matsueda: Innovator in Pharmaceutical Chemistry
Introduction
Yohei Matsueda is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on pyrazolo[1,5-a]pyridine derivatives. His research focuses on developing compounds that exhibit valuable therapeutic properties.
Latest Patents
Matsueda holds a patent for pyrazolo[1,5-a]pyridine derivatives or pharmaceutically acceptable salts thereof. This compound, represented by formula (I), demonstrates excellent MAPKAP-K2 inhibitory activity. Medicines containing this compound as an active ingredient are anticipated to be effective in treating or preventing diseases mediated by MAPKAP-K2, including inflammatory injury, autoimmune diseases, asteropathia destruens, cancer, and tumor growth. He has 1 patent to his name.
Career Highlights
Matsueda is currently employed at Teijin Pharma Limited, where he continues to advance his research in pharmaceutical development. His work has garnered attention for its potential impact on various medical conditions.
Collaborations
Matsueda collaborates with notable colleagues, including Gen Unoki and Yoshiyuki Matsumoto. Their combined expertise contributes to the innovative research environment at Teijin Pharma Limited.
Conclusion
Yohei Matsueda's contributions to pharmaceutical chemistry, particularly through his patented work on pyrazolo[1,5-a]pyridine derivatives, highlight his role as a key innovator in the field. His ongoing research promises to advance the treatment of significant medical conditions.